Premium
The novel coronavirus disease (COVID‐19) complicated by pulmonary embolism and acute respiratory distress syndrome
Author(s) -
Li Ting,
Cheng GuangShing,
Pipavath Sudhakar N. J.,
Kicska Gregory A.,
Liu Liangjin,
Kinahan Paul E.,
Wu Wei
Publication year - 2020
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26068
Subject(s) - covid-19 , virology , medicine , acute respiratory distress , coronavirus , pulmonary embolism , respiratory distress , respiratory system , respiratory disease , disease , pneumonia , betacoronavirus , intensive care medicine , lung , infectious disease (medical specialty) , outbreak , anesthesia
Abstract Acute respiratory distress syndrome and coagulopathy played an important role in morbidity and mortality of severe COVID‐19 patients. A higher frequency of pulmonary embolism (PE) than expected in COVID‐19 patients was recently reported. The presenting symptoms for PE were untypical including dyspnea, which is one of the major symptoms in severe COVID‐19, especially in those patients with acute respiratory distress syndrome (ARDS). We reported two COVID‐19 cases with coexisting complications of PE and ARDS, aiming to consolidate the emerging knowledge of this global health emergency and raise the awareness that the hypoxemia or severe dyspnea in COVID‐19 may be related to PE and not necessarily always due to the parenchymal disease.